Biotech Connection Singapore

[Event information from ENMORE BIO] BIOCHINA 2025 International Convention @ Suzhou International Expo Centre - March 13-15 2025 🌟 Why Attend BIOCHINA 2025? 🌟 BIOCHINA is the premier platform advancing China's biotech industry through innovation and collaboration. With over 3,000 Chinese biotech companies participating, this event is your gateway to connect with key decision-makers and industry pioneers. 🧬 Spotlight on ADCs, Cell & Gene Therapy BIOCHINA 2025 will feature specialized forums on antibody-drug conjugates (ADCs), cell therapy, gene therapy, and more. Discover the latest breakthroughs and engage in discussions on early-stage drug development and CMC technologies that are shaping the future of medicine. 🤝 Partnerships & Collaborations Join industry leaders like Roche, Pfizer, and Novo Nordisk, along with 3,000 Chinese biotech companies and 500+ upstream suppliers. BIOCHINA fosters an environment where global partnerships flourish. Don't miss your chance to be part of the action! 🚀 Special Offer: 20% Discount on Partnering Registration Sign up by 31st October 2024 to secure your spot and take advantage of our exclusive 20% discount on Partnering registration! Network with biotech founders, investors, and business development leaders through our 30-minute one-on-one partnering sessions. 🔍 BIOCHINA 2025 Details 📅 Dates: March 13-15, 2025 📍 Location: Suzhou, China 📏 Exhibition Area: 50,000 sqm covering cutting-edge technologies and services across five halls. 💡 BIOCHINA 2025 is set to be the biggest event yet—don’t miss out on being at the forefront of biotech innovation in China! For more information, please refer to the BIOCHINA website. https://lnkd.in/gv3JpqWY For registration, please refer to this link: https://shorturl.at/hfCGs Please email marketing@biotechconnection-sg.org to receive the 20% discount promo code. 

[Event information from Singapore-ETH Centre (SEC)] 🌟𝐈𝐧𝐯𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐭𝐨 𝐀𝐩𝐩𝐥𝐲 𝐟𝐨𝐫 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 (𝐏𝐃𝐓𝐱) 𝐌𝐚𝐬𝐭𝐞𝐫 𝐂𝐥𝐚𝐬𝐬 The Precision Digital Therapeutics (PDTx) Master Class, taking place from 12 𝐭𝐨 17 𝐉𝐚𝐧𝐮𝐚𝐫𝐲 2025, is hosted by Future Health Technologies (FHT) at the Singapore-ETH Centre; Nanyang Technological University (NTU); and the Centre for Healthcare Innovation (CHI). 𝐀𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐌𝐚𝐬𝐭𝐞𝐫 𝐂𝐥𝐚𝐬𝐬: Digital Therapeutics (DTx) are software-based interventions aimed at treating diseases. In this Master Class, we will explore Precision Digital Therapeutics (PDTx), which leverages cutting-edge technologies to deliver personalised interventions at optimal moments to enhance adherence and improve outcomes. Over five days, participants will collaborate in interdisciplinary teams to develop PDTx prototypes for real-world healthcare challenges presented by medical experts, caregivers, and patients. 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐌𝐚𝐬𝐭𝐞𝐫 𝐂𝐥𝐚𝐬𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: -Lectures by international experts from medical, technical, and business fields -Hands-on coaching using advanced PDTx and GenAI tools -Team-based prototyping, with a final presentation to a jury of clinicians, patients, and investors 𝐖𝐡𝐨 𝐒𝐡𝐨𝐮𝐥𝐝 𝐀𝐩𝐩𝐥𝐲? Early career researchers (e.g., PhD students and postdoctoral researchers) from a variety of disciplines 🗓️ 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 13, 2024 For more information on how to apply, visit SEC’s website. https://lnkd.in/gkpCYTeK

[Event information from JLABS Singapore] 𝗛𝗲𝗿𝗱𝗶𝗻𝗴 𝗰𝗮𝘁𝘀: 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗳𝗼𝗿 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 The goal of life science business development professionals is to optimize optionality and long-term value at each stage of its company’s life. What are the ins-and-outs of making a partnership? How do you determine the direction that will add the most value to your company? All the way from California, we are pleased to host an event led by Lesley Stolz, Regional VP of Early Innovation Partnering at Johnson & Johnson Innovation, on her signature session titled Herding cats: Business development for life science companies. Register now to hear from Lesley and industry business development professionals on fundamental BD skills to help you successfully evaluate and manage strategic alliances and other potential growth opportunities. Date: Tuesday, September 24 Time: 3:30PM - 7:00PM (Registration begins at 3:30PM) Location: Guoco Midtown Network Hub (Level 2), 126 Beach Road, Singapore 189772 Please find details and register for the event here: https://lnkd.in/gt_V8v99

NTU CoS Innovation Day 2024 The NTU College of Science (CoS) comprises the School of Physical and Mathematical Sciences (SPMS), School of Biological Sciences (SBS), School of Chemistry, Chemical Engineering and Biotechnology (CCEB), and Asian School of the Environment (ASE). This inaugural NTU CoS Innovation Day will bring together selected research experts from all the Schools to share about their scientific discoveries and technological solutions to address the needs of industry and society. Join us to learn about their innovation and to hear from Xora Innovation and SGInnovate on the ins and outs of translation and commercialisation of technologies! 📅: 23 October 2024, Wednesday 🕓: 8:30am to 3.30pm 📍: Nanyang Technological University, School of Biological Sciences, SBS Classroom 1 (Level 1)    60 Nanyang Drive, Singapore 637551 ✍ Click the following link to find out more and register: https://lnkd.in/gqhCH_ek #science #innovation

We recently partnered SGInnovate for the 2nd run of the Biotech Entrepreneur Community of Practice Roundtable with Tuyen Ong, CEO of Ring Therapeutics and CEO-Partner of Flagship Pioneering. This invite-only mentoring session was focused on helping founders and c-suite level executives of startups learn from the experiences of Tuyen Ong, a seasoned bioentrepreneur. He started the session answering the burning questions prepared by a number of the participants, followed by focusing on career planning, career development and fundraising. He also gave personalised advice and feedback to participants who sought help. We would like to thank our participants for being very active in the discussions. This enabled everyone to learn from one another and it definitely made the session a more enjoyable one! Once again, we greatly appreciate Tuyen Ong for mentoring biotech entrepreneurs in Singapore. We hope to continue this partnership with you! We would also like to thank our co-organisers: Vanessa Phua and Jerry Lui. #biotech #bioentrepreneurship #mentorship #founder

BCS Career Interviews – So you want to work in IP? IP is important for biotech companies and an alternative route after academia. How does someone enter this industry? What does daily work entail? In this interview article, Anni Wang, Ding Jie ANG and Seng Koon L. discuss their experiences in #IPinbiotech! Read the article here: https://lnkd.in/gycVAPrv #IP #lifesciences #biotech

Are you ready to take your expertise in drug development to the next level? Join us for our lunchtime workshop on Biomarker Discovery and Target Product Profile (TPP) Development co-organised by Merck Group Singapore and Biotech Connection Singapore! 🎯 Why Attend? Biomarkers play a pivotal role in the drug development process, guiding everything from initial discovery to clinical validation. This workshop by Merck's David Loong and Eng Hwa Yeo, PhD will provide you with cutting-edge insights on: Biomarker discovery: Understand the critical role biomarkers play in identifying therapeutic targets and predicting patient response. Learn the importance of developing robust assays for biomarker validation to ensure reliability and reproducibility. Learn how they contribute to defining TPP. TPP development: Learn about the key elements of a TPP, including safety, efficacy and patient population. Master the creation of a TPP that aligns with both regulatory requirements and market needs, ensuring your product’s success. Case Studies & Real-World Applications: Analyze real-world examples to understand the challenges and solutions in biomarker and TPP development. Q&A: Learn from the panel discussion by David Loong, Eng Hwa Yeo, PhD and Phyllis Xiu Li Gan. 📅: 12 September 2024, Thursday 🕓: 11:30am to 1.30pm (Refreshments provided) 📍: NSG Biolab Site 1, 21 Biopolis Rd, # 02-03/05 Click the following link to register: https://bit.ly/3yYxUje

What should founders know about fundraising in today’s competitive landscape? 💡 Last week, Gunderson Dettmer and Biotech Connection Singapore hosted a session packed with valuable insights. Jonathan Pentzien expertly distilled the fundamentals of venture financing, followed by a compelling discussion with our Therapeutics Lead Wen Qi Ho and MissionBridge’s Ritika Khetawat on what founders should consider before fundraising. Key takeaways: 𝗧𝗲𝗮𝗺 𝗺𝗮𝘁𝘁𝗲𝗿𝘀: 👥 Investors look beyond the CEO. A strong team with expertise in key roles like discovery and research is crucial. 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀 𝗺𝗮𝘁𝘁𝗲𝗿: 🤝 The type of capital around the table can influence investor interest. 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘁𝘁𝗲𝗿𝘀: 🚀 A unique and competitive technology is essential to attract investors. A special thanks to co-organizers Brendan Sieow, Beverly Mok, Xun Hui Y. and Grace Wong! #clavystbio #venturefinancing #startups

BCS interview with Dr Damien Keogh, founder and CEO of BluMaiden Biosciences. BluMaiden is revolutionizing drug discovery by combining AI and clinical data to fast-track drug development.  Read on as Dr Keogh discusses his experience starting and growing a #techbio company in Singapore. Read the article here: https://lnkd.in/gduR-cFR #biotech #techbio #AI #startup #drugdiscovery

We would like to thank everyone who joined us at the "Biotech Fundraising: Opportunities and Challenges" event, hosted by Gunderson Dettmer Singapore and Biotech Connection Singapore last week! We had the privilege of having Jonathan Pentzien, Managing Partner at Gunderson Dettmer Singapore deliver a masterclass on venture financing basics, focusing on key fundraising considerations for early-stage biotech startups. The following fireside chat comprised of our esteemed panelists: Wen Qi Ho, Therapeutics Lead at ClavystBio and Ritika Khetawat, Founder at MissionBridge, with Jonathan Pentzien as the moderator. The panel shared the different perspectives of a fundraiser and an investor when it came to the expectations, challenges and best practices in biotech fundraising. We are grateful to our three speakers for sharing their expertise and insights, and for answering all the difficult questions from the audience! 🙏 Special thanks to our co-organisers: Grace Wong from Gunderson Dettmer and Patricia Lee from ClavystBio. We hope to work with you again! Do check out Gunderson Dettmer and Gunderson Dettmer Asia's Linkedin page for more information! Headquartered in Silicon Valley, Gunderson Dettmer’s Singapore office is consistently recognized by Pitchbook’s Global League tables as the “most active venture capital law firm” in Southeast Asia and India. Gunderson represents life sciences clients headquartered around the world, from founders who are spinning intellectual property out of universities to venture-backed and public companies, as well as venture capital and growth equity firms focused on investing in those industries. Beverly Mok | Xun Hui Y. | Andrew Lee | Sungmin Shin | Zara Chung | James Ho | Brendan Sieow